Chemodex

Omeprazole sulfide

CHF 41.00
In stock
CDX-O0041-M02525 mgCHF 41.00
CDX-O0041-M250250 mgCHF 135.00
More Information
Product Details
Synonyms Omeprazole impurity C (PhEur); Pyrmetazol; Ufiprazole
Product Type Chemical
Properties
Formula

C17H19N3O2S

MW 329.42
CAS 73590-85-9
Purity Chemicals ≥97% (NMR)
Appearance White to off-white powder.
Solubility Soluble in DMSO (10mg/ml), DMF (10mg/ml) or ethanol (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key XURCIPRUUASYLR-UHFFFAOYSA-N
Smiles CC(C(OC)=C(C)C=N1)=C1CSC2=NC3=CC(OC)=CC=C3N2
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Omeprazole sulfide is an aryl hydrocarbon receptor (AhR) antagonist. Omeprazole sulfide is an intermediate used in the production of the gastric proton pump inhibitors, omeprazole and esomeprazole. Omeprazole sulfide is also a degradation product (Omeprazole Impurity C) of Omperazole, and it is reported to be a direct-acting inhibitor of cytochrome P450 2C19 in pooled human liver microsomes. Omeprazole is a selective and irreversible proton pump inhibitor. It suppresses stomach acid secretion by specific inhibition of the H+/K+-ATPase system found at the secretory surface of gastric parietal cells. Because this enzyme system is regarded as the acid (proton, or H+) pump within the gastric mucosa, omeprazole inhibits the final step of acid production. Omeprazole sulfide can be usd as reference material.

Product References

(1) S. Gerbal-Chaloin, et al.; Cell Signal. 18, 740 (2006) | (2) B.W. Ogilvie, e al.; Drug Metab. Dispos. 39, 2020 (2011) | (3) L. Olbe, et al.; Nat. Rev. Drug Discovery 2, 132 (2003) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.